The auditory steady-state response (ASSR) is a nearly sinusoidal electrical response of the brain to auditory stimuli delivered at fast rates. The amplitude of the response is largest for stimulus rates near 40/s, hence the label 40-Hz ASSR. We have studied the effects of propofol (1.5 mg/kg) on the 40-Hz ASSR in 14 patients. The spectral edge frequency (SEF) and median frequency (MDF) of the electroencephalogram were recorded for comparison. The study was limited to 6 min after the injection of propofol. Recordings were obtained every minute. Consciousness, defined as responsiveness to verbal command, was assessed before each recording. Propofol caused unconsciousness in all patients within 1 min. Nine patients regained consciousness before the end of the study. Propofol caused disappearance of the 40-Hz ASSR for 2 min. The 40-Hz ASSR reappeared afterward, reaching, at the end of the study period, an amplitude of about 65% of baseline. Recovery of the 40-Hz ASSR occurred whether or not consciousness was regained during the study, but the amplitude tended to be larger in patients who had regained consciousness compared with patients still unconscious during the same recording. The SEF was reduced by 24% within 2 min and recovered more quickly than the 40-Hz ASSR, reaching 91% of baseline within 4 min. The SEF tended to be higher in patients who had regained consciousness. The MDF was reduced by 27% within 2 min, and exceeded baseline values by 25% during recovery. The MDF was not higher in patients who had regained consciousness. We conclude that propofol transiently abolishes the 40-Hz ASSR. Recovery of the 40-Hz ASSR occurs whether or not consciousness is regained, but the 40-Hz ASSR tends to be larger after the return of consciousness. An association between higher amplitude 40-Hz ASSR and the return of consciousness could not be conclusively established, perhaps because of low signal-to-noise ratio in three patients. The 40-Hz ASSR did not offer any clear advantage over the SEF in predicting the return of consciousness.
The auditory steady-state response (ASSR) is a nearly sinusoidal electrical response of the brain to auditory stimuli delivered at fast rates. The amplitude of the response is largest for stimulus rates near 40/s, hence the label 40-Hz ASSR. We have studied the effects of propofol (1.5 mg/kg) on the 40-Hz ASSR in 14 patients. The spectral edge frequency (SEF) and median frequency (MDF) of the electroencephalogram were recorded for comparison. The study was limited to 6 min after the injection of propofol. Recordings were obtained every minute. Consciousness, defined as responsiveness to verbal command, was assessed before each recording. Propofol caused unconsciousness in all patients within 1 min. Nine patients regained consciousness before the end of the study. Propofol caused disappearance of the 40-Hz ASSR for 2 min. The 40-Hz ASSR reappeared afterward, reaching, at the end of the study period, an amplitude of about 65% of baseline. Recovery of the 40-Hz ASSR occurred whether or not consciousness was regained during the study, but the amplitude tended to be larger in patients who had regained consciousness compared with patients still unconscious during the same recording. The SEF was reduced by 24% within 2 min and recovered more quickly than the 40-Hz ASSR, reaching 91% of baseline within 4 min. The SEF tended to be higher in patients who had regained consciousness. The MDF was reduced by 27% within 2 min, and exceeded baseline values by 25% during recovery. The MDF was not higher in patients who had regained consciousness. We conclude that propofol transiently abolishes the 40-Hz ASSR. Recovery of the 40-Hz ASSR occurs whether or not consciousness is regained, but the 40-Hz ASSR tends to be larger after the return of consciousness. An association between higher amplitude 40-Hz ASSR and the return of consciousness could not be conclusively established, perhaps because of low signal-to-noise ratio in three patients. The 40-Hz ASSR did not offer any clear advantage over the SEF in predicting the return of consciousness. (Anesth Analg 1996; 82:1015-22) amplitude of the 40-Hz ASSR is reduced by approximately 50% during sleep (8-10). The 40-Hz ASSR is profoundly attenuated or abolished during surgical anesthesia (11, 12) . The 40-Hz ASSR remains maximally attenuated when the concentration of isoflurane or enflurane is decreased to a level just sufficient to maintain unconsciousness (isoflurane 0.5% end-tidal in oxygen; enflurane 0.5% end-tidal and 66% nitrous oxide in oxygen) (11, 12) . After terminating the administration of isoflurane or enflurane, the recovery of consciousness (defined as responsiveness to verbal commands) coincides with the sudden reappearance of the 40-Hz ASSR. These observations suggest that the 40-Hz ASSR might be useful to monitor the effects of anesthetics on consciousness.
The 40-Hz ASSR may be viewed as a way to assess the capability of the auditory system to sustain endogenous "40-Hz"i or y rhythms which are believed to be 
Methods
The study was approved by the institutional Ethics Committee. Sixteen ASA physical status I patients between 18 and 50 yr of age and scheduled for elective surgery were enrolled after signed informed consent. All were within the ideal body weight range (Metropolitan Weight Tables, 1983) , denied past neurological or otological disease, and had normal otoscopy. Fourteen patients (aged 23-49 yr, mean 34 yr) completed the study. Two other patients were excluded because they became agitated after the injection of propofol.
(No recordings could be obtained in these two patients because of movement artifacts.) No premeditation was given. After insertion of an intravenous cannula in the left arm and placement of monitors (electrocardiogram, blood pressure cuff, and pulse oximetry probe) patients breathed oxygen by face mask for 3 min. Three baseline recordings of the 40-Hz ASSR were then obtained, one every minute. Propofol (1.5 mg/kg) was given over 15 s and the 40-Hz ASSR recorded every minute for 6 min, starting with the beginning of the injection. Before each recording, the level of consciousness was assessed by asking the patients to open their eyes or to squeeze the fingers of an observer unaware of the 40-Hz ASSR results. A patient who obeyed either or both commands was considered conscious. Spontaneous movements were noted. When a patient regained consciousness before the end of the study, one recording was obtained after the return of conciousness. At 6 min after the injection of propofol, or after the recording following the regaining of consciousness, the study was terminated. Additional propofol was given to ensure unconsciousness before proceeding with standard anesthetic care. While in the recovery room after surgery the patients were asked to describe what they remembered from the induction period.
A microcomputer was used for controlling stimulus delivery and recording of the electroencephalogram (EEG). The stimuli were 500 Hz tonebursts (10 ms duration; 2 ms increase and decrease time; 84 dB peak equivalent sound pressure level) delivered binaurally at the rate of 40/s via insert earphones
("E-A-R TONE" 3A; Cabot Corporation, Indianapolis, IN). The stimulus waveform (gated continuous sine wave) was created by the microcomputer, fed through a digitalto-analog converter (digital-to-analog rate, 20 kHz), and attenuated prior to reaching the earphones to obtain 84 dB.
The EEG was recorded from C, (20) with goldplated cup electrodes filled with conductive gel. The reference was the right mastoid and the ground was on the back of the neck over the fifth cervical vertebra. Impedances were kept below 3 kfl (at 30 Hz). The EEG was amplified (amplifier model 12A5; Grass Instruments Co., Quincy, MA) with a bandpass of 0.3-100 Hz. The analog-to-digital sampling rate was 298.978 Hz with 1024 data points per channel, yielding an epoch duration of 3.425 s. The analog-to-digital resolution was 12 bits. Epochs contaminated by excessive artifacts were rejected. The criterion for rejection was 10% or more data points exceeding 5 100 pV. Epochs were averaged by groups of 10.
40-Hz ASSR Measurements
Amplitude (baseline to peak) and phase (sine function) at 40-Hz was obtained by computing the fast Fourier transform (FFT) (21) of the averaged waveforms. No windowing was used because the choice of the sampling frequency ensured that there would be a FFT term exactly at 40 Hz. The average amplitude (and SD) from 35 to 45 Hz was recorded to express as a z score the amplitude at 40 Hz relative to adjacent frequencies.
SEF and MDF Measurements
Because averaging uniformly attenuates all frequencies, it is possible to obtain an estimate of the power spectrum of the EEG from the averaged waveforms (22) . A nonphase shift FFT-based digital filter (21) was used to remove residual noise below 2.0 Hz and above 32 Hz. The power spectrum of the averaged waveforms was computed by FFT with a Hanning window. The frequency below which 50% and 95% of the total power was present was recorded as the SEF (23) and MDF, respectively. The presence of evoked activity (40-Hz ASSR) does not interfere with this process, because it is outside the frequency range used for determining the SEF and MDF (22).
Changes of the 40-Hz ASSR amplitude and of the SEF and of the MDF were evaluated with paired t-tests. Paired t-tests were used in lieu of analysis of variance (ANOVA) for repeated measures because the number of observations varied with time. An ANOVA for repeated measures was used to evaluate a progressive increase in amplitude of the 40-Hz ASSR during baseline recordings (24). The Pearson productmoment correlation coefficient (25) was used to evaluate the relationships between the 40-Hz ASSR and the SEF and the MDF at each assessment time. The runs test above and below the median (26) was used to evaluate differences between conscious and unconscious patients. The Bonferroni correction (24) was used to reduce the likelihood of spurious significance.
The reliability of the individual 40-Hz ASSR recordings was evaluated with z scores, which determine whether the amplitude of 40-Hz was larger than at adjacent frequencies (27). This ascertains whether the response can be reliably distinguished from background noise. The equation is: z = (a, Hz -m,,, &/S,,, HZ, where a,, Hz is the amplitude at 40 Hz, ma,, Hz is the mean amplitude between 35 and 45 Hz, including the value at 40 Hz, and S3s45Hz is the SD. (The number of amplitude values obtained from the FFT for the interval 35-45 Hz is 35; i.e., the mean is based on 35 observations.) Assuming a normal distribution, the probability that a z score exceeds 2 is 0.023 (25). The amplitude at 40-Hz was therefore considered to probably exceed that of adjacent frequencies if the z score was 2 or more.
There are instances where the 40-Hz ASSR is too small to appear on the amplitude spectrum, but can, nevertheless, be identified because the phase at 40 Hz across multiple recordings is not random, a phenomenon called "phase coherence." Phase may be viewed as the steady-state equivalent of latency for transient responses (such as somatosensory evoked potentials for spinal cord monitoring). The Rayleigh test (28) was used to determine whether the level of phase coherence exceeded chance level. Phase coherence (C) is defined as C = [(average sine)' + (average cosine)*]i'* where sine and cosine are those of the phase at 40 Hz from each patient. C ranges from 0 (no response) to 1 (perfectly synchronized response).
Results
All patients were unconscious before the recording started 1 min after propofol. The number of patients who had regained consciousness before the recordings started at 2,3,4, and 5 min after propofol was, respectively, four, two, two, and one. Therefore, nine patients became conscious before the end of the study period. Only one patient remembered having awakened after the injection of propofol. Seven patients moved their arms or feet while unconscious after the injection of propofol. The movements were not purposeful and occurred at various times after the injection. There was no relationship between occurrence of movements and the amplitude of the 40-Hz ASSR or the value of the SEF or MDF. The range of values observed when the patients moved was 0.05-0.19 PV for the 40-Hz ASSR, 11.1-23.1 Hz for the SEF, and 3.2-13.1 Hz for the MDF. The amplitude of the 40-Hz ASSR measured from individual patients is shown in Figure 1 , and the grand average waveforms (in which all patients are pooled in a single recording by averaging) are shown in Figure 2 . The apparent increase in amplitude during the three baseline recordings did not approach significance (repeated-measures ANOVA, df 2,26, F = 0.47, P = 0.63). The z scores during baseline were (mean [SD] ) 4.3 [0.9], 4.3 10.91, and 4.5 11.01 for the recordings started 3, 2, and 1 min before propofol, respectively. There were three outliers [defined as values outside mean 2 2 SD (25)l: one patient had a z score of 1.7 for the recording started 3 min before the injection; another patient had z scores of 2.0 and 1.6 for the recordings started 2 and 1 min before injection, respectively. Inspection of the original recordings revealed no anomaly, but substantial residual noise. The for the z score of 1.6. Propofol caused a 50% amplitude reduction during the recording started concurrently with the injection and an 85% reduction for the recording started 1 min after injection (Figure 1) . No response can be identified on grand-average waveform for recordings started 1 min after the injection (Figure 2) . The apparent discrepancy for the recording started 1 min after injection between the grand-average waveform (Figure 2) , which shows no activity at 40 Hz, and the measures taken from individual patients (Figure l ), which show a mean of 0.09 PV (range, 0.00-0.15 PV) is attributable to the higher level of residual noise in the individual recordings. This is supported by the loss of phase coherence and by the observation that only one patient yielded a z score greater than 2 during the recording started 1 min after injection.
For the subsequent recordings, the results obtained while the patients remained unconscious will be presented first. The response remained absent for the recording which started at 2 min. During the following recordings, there was a progressive increase in the amplitude of the 40-Hz ASSR. For statistical analysis, the average amplitude of the three baseline recordings was compared to subsequent recordings and the amplitude at each time (from 0 to 4 min) compared to the following recording (0 vs 1 min; 1 vs 2 min, etc.) with 11 paired t-tests. The P value required for an overall P < 0.05 criterion was 0.05/11 or 0.0045. The amplitude at baseline exceeded that at all other times (P < 0.002), and the amplitude at Time 0 exceeded that of Time 1 min 0' < 0.001). The number of unconscious patients The values from 2 to 5 min are for unconscious patients only. There were not enough conscious patients at each time for testing phase coherence. The loss of phase coherence during the recording started 1 and 2 min after injection indicates that the response has been abolished by propofol.
Nine patients regained consciousness before the end of the study. In six of these nine patients, a 40-Hz ASSR could be unequivocally demonstrated during the recording obtained immediately after the return of consciousness (amplitude 0.15 PV or more with z scores of 2 or more). The three remaining patients had amplitudes of 0.09, 0.14, and 0.23 PV with z scores of -2.0, 0.2, and 0.1, respectively. This combination of amplitudes and z scores indicates high levels of residual noise. If the nine patients who regained consciousness are ranked by the level of residual noise (measured as the mean amplitude over the interval 35-45 Hz), the three patients with z scores less than 2 rank first, third, and fourth. The amplitude required to obtain a z score of 2.0 given the level of residual noise is 0.19,0.25, and 0.40, respectively. This is higher than the lowest amplitudes (0.10-0.15 PV) observed after the return of consciousness after anesthesia with isoflurane or enflurane (11, 12) . It is therefore not possible to determine whether a response was present in these patients. Interestingly, two of these three patients yielded low outlier z scores during baseline Figure 3 .
The amplitude of the 40-Hz ASSR after the return of consciousness was in general higher than that of patients who were still unconscious at the corresponding time (Figure 1 ; also compare the right and left columns of Figure 2) . In all six patients for whom the 40-Hz ASSR could be reliably recorded (i.e., z scores of 2.0 or above), the amplitude after the return of consciousness was higher than the median amplitude for all patients at the corresponding time (P = 0.016, median run test, Bonferroni criterion = 0.05/3 = 0.017). If all patients who regained consciousness are included, seven of nine patients had an amplitude larger than the median amplitude (P = 0.09, median run test). The SEF was reduced by only 5% during the recording started concurrently with the injection of propofol and by 24% during the recording started 1 min after injection (Figure 4) .
For the subsequent recordings, the results obtained while the patients were unconscious will be presented first. There was a rapid return toward baseline values, the SEF having recovered to 91% of baseline for the recording started 3 min after injection. A statistical analysis, identical to that used for the 40-Hz ASSR, revealed that the baseline value exceeded the values at Times 1 and 2 min (P < 0.001) and the value at Time 0 exceeded the value of Time 1 min V' < 0.004). run test, Bonferroni criterion = 0.017). Despite larger SEF values in conscious patients, recovery of the SEF to baseline values did occur before the return of consciousness.
The SEF recorded after the return of consciousness was in general higher than that of patients who were still unconscious at the corresponding time (Figure 4 ). For eight of the nine patients, the SEF in conscious patients was higher than the median SEF for all patients at the corresponding time (P = 0.018, median
The MDF was reduced by 10% during the recording started concurrently with the injection, and by 27% for the recording started 1 min after injection ( Figure 5 ). For the subsequent recordings, the results obtained while the patients were unconscious will be presented first. During the subsequent recording, the MDF exceeded baseline values. The difference between the baseline recording and 1-min recording approached significance (P < 0.008; Bonferroni criterion = 0.0045), as did the difference between baseline and 3-min recordings (P < 0.02) and between the 1-min and 2-min recordings (P < 0.02). The MDF recorded after the return of consciousness was not much different from that of patients still unconscious at the corresponding time ( Figure 5 ). Only six of nine patients had a MDF higher than the median MDF of the corresponding time (P = 0.16, median run test).
There were four apparent outliers (values outside mean i 2 SD) during the baseline recordings: one during the first recording (4.2 Hz), two during the second (14.6 and 15.5 Hz), and one during the third recording (16.6 Hz). The 15.5-Hz and 16.6-Hz values were from the same patient. There were therefore three patients with outliers. We repeated the statistical analysis after having excluded these three patients. There were some minor changes in the results of the analysis, but in no instance did a previously nonsignificant difference become significant.
Because there are nine assessment times, the P value required to obtain an overall error of 0.05 for each pair of measures is 0.0056. During the baseline recording, there was a trend (P < 0.05) toward a correlation between MDF and SEF for the recording started 3 min before injection (u = 0.59) and between MDF and the amplitude of the 40-Hz ASSR for the recording started 1 min before the injection (Y = 0.57). Removing the three patients with outliers, values for the MDF did not change the outcome of the analysis. There was an almost significant (P < 0.006) correlation between the amplitude of the 40-Hz ASSR and the SEF for the recordings started 4 min after the injection (Y = 0.94). There was a trend toward a correlation between the SEF and MDF at 2 min (P < 0.05; Y = 0.79) and 5 min (P < 0.05; Y = 0.89) postinjection.
The above correlations for recordings obtained after injection are based only on patients still unconscious before the recording.
Discussion
Despite the short recording time (34.25 seconds), all individual baseline recordings except three yielded a clearly identifiable 40-Hz ASSR. The exceptions involved two patients. One had an isolated low (1.7) z score. The other had one low (1.6) and one borderline (2.0) z score, indicating that the response was labile in this patient. There is a possible but unconfirmed explanation for this lability. The stimulation rate yielding the largest response is near 40 Hz for most subjects, but may range from 20 to 55 Hz (2). Of 14 subjects tested by these authors, maximum amplitude was observed at 20 Hz in one, at 30 Hz in another, at 40 Hz in five, at 45 Hz in six, and at 50 Hz in one. We now routinely search for the rate yielding the largest response in each patient and use this stimulation rate. We have noted that when there is a difference of 10 Hz or more between the actual and optimal stimulation rates, the response is less consistently observed. Whether this phenomenon could account for response lability in these two patients was not verified, because it was not practical to recall the patients for further testing.
Propofol caused a transient disappearance of the 40-Hz ASSR followed by recovery to an amplitude of nearly 65% of baseline values. Contrary to our prediction, recovery of the 40-Hz ASSR occurred whether or not consciousness (defined as responsiveness to verbal commands) was regained. Therefore, reappearance of the 40-Hz ASSR after propofol anesthesia does not necessarily indicate that consciousness has returned. This contrasts with results obtained during emergence from anesthesia with isoflurane (11) or enflurane (12). With these drugs, recovery of consciousness and the reappearance of the 40-Hz ASSR coincided. Although this difference between propofol and the volatile drugs may be attributed to drug-specific effects, other factors must be considered, most notably the longer duration of administration of the volatile drugs. The amplitude of the 40-Hz ASSR in patients who had just regained consciousness tended to be larger than that of patients still unconscious at the corresponding time (Figure 2 ). An association between larger 40-Hz ASSR and the return of consciousness could not be conclusively demonstrated, however. Of the nine patients who regained consciousness before the end of the study, the recovery of the 40-Hz ASSR was confirmed by z scores greater than 2.0 in six patients. For these patients, the amplitude was significantly larger than the amplitude observed in unconscious patients. The difficulty arises with the three remaining patients who yielded z scores less than 2.0. Low z scores can be explained by high level of residual noise, but also by a small 40-Hz ASSR response. There is suggestive evidence that excessive residual noise was the main factor, but this does not rule out a small amplitude 40-Hz ASSR. It probably is no coincidence that two of these three patients had at least one low z score value during baseline recordings. The present evidence can only be considered weakly supportive of an association between the return of consciousness and larger 40-Hz ASSR. Longer recording time would have reduced residual noise and would have perhaps allowed us to avoid having patients in whom the 40-Hz ASSR could not be properly assessed. Longer recording time would also have limited our ability to correlate the amplitude of the 40-Hz ASSR with sudden changes in the level of consciousness. There are sophisticated methods for detecting steady-state responses buried in noise (29) but they require lengthy computations and would be impractical. To continue the study of the relationships between the 40-Hz ASSR and consciousness during propofol anesthesia, the preferred approach would now be to use continuous infusions to achieve stable concentrations.
Propofol significantly reduced the SEF. Its effect on the SEF was less pronounced than on the 40-Hz ASSR (24% reduction compared with 85%), occurred one minute later and recovered more quickly (91% recovery at three minutes versus 65% at five minutes). Like the 40-Hz ASSR, the SEF after the return of consciousness tended to be higher than that of patients still unconscious at the corresponding time. There was nevertheless much overlap between the SEF of conscious and unconscious patients. We found no prior study of the effects of propofol alone on the SEF. Hazeaux et al. (30) found that the effects of propofol in the unprocessed EEG were similar to that of the other short-acting intravenous anesthetics, except for the absence of 12-14 Hz "sleep" spindles during propofol anesthesia. It is therefore not surprising that the effects of propofol on the SEF resemble those of thiopental (23).
The mean baseline value for MDF was as expected (31,321, but there were three patients with outliers, for which we have no good explanation. We used averaged waveforms for spectral estimation instead of the usual approach based on individual epochs (31,32), but it is hard to understand how this could lead to more frequent outliers. In any case, the results are the same, whether or not these three patients are included in the analysis. The reduction of MDF by propofol was similar to that of SEF, but recovery was faster and yielded values above baseline. A similar phenomenon was observed by Forrest et al. (31) in some of their patients during anesthesia with propofol given as a bolus (0.6-1.1 mg/kg), followed by infusion. These authors were, however, unable to demonstrate for the entire study group any consistent change of the MDF as a function of time, dose, or concentration of propofol. Schuttler (32), however, found consistent reduction of MDF to 2 Hz during unconsciousness induced by propofol infusion (Figure 15 of ref. 32) . The discrepancy between the observations of Schiittler versus those of Forrest et al. and our own may perhaps be explained by differences in the rate of administration of propofol.
There was no consistent correlation between any two of the three measures (40-Hz ASSR, SEF, MDF). This is not surprising, because cerebral rhythmic activities of different frequencies depend on different basic mechanisms (33, 34) . The lack of consistent correlations after propofol would seem to suggest that propofol does not have a unitary effect on these mechanisms.
We conclude that propofol (1.5 mg/kg) transiently abolishes the 40-Hz ASSR. Recovery of the 40-Hz ASSR occurs whether or not consciousness is regained, but the 40-Hz ASSR tends to be larger after the return of consciousness. An association between higher amplitude and the return of consciousness could not be demonstrated, perhaps because of low signal-to-noise ratio in some patients. Propofol has a similar effect on the SEF, but the effect was less pronounced and recovered more quickly. The 40-Hz ASSR did not offer any advantage over the SEF in predicting the return of consciousness. 
